(Q57265399)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

title

European evidence-based Consensus on the diagnosis and management of ulcerative colitis: Definitions and diagnosis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

0 references

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

Peter Laszlo Lakatos

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

author name string

E F Stange

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S P L Travis

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

W Reinisch

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

K Geboes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

A Barakauskiene

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

R Feakins

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

J F Fléjou

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

H Herfarth

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

D W Hommes

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

L Kupcinskas

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

G J Mantzaris

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

S Schreiber

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

V Villanacci

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

B F Warren

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

European Crohn's and Colitis Organisation (ECCO)

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

publication date

18 January 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

Journal of Crohn's and Colitis

18 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

page(s)

1-23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

Incidence of inflammatory bowel disease across Europe: is there a difference between north and south? Results of the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD)

18 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Recent trends in the epidemiology of inflammatory bowel diseases: up or down?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Guidelines for the management of inflammatory bowel disease in adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

[Diagnosis and therapy of ulcerative colitis: results of an evidence based consensus conference by the German society of Digestive and Metabolic Diseases and the competence network on inflammatory bowel disease]

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Overlap in the spectrum of non-specific inflammatory bowel disease--'colitis indeterminate'

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Cortisone in ulcerative colitis; final report on a therapeutic trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

The management of acute severe colitis: ACPGBI position statement

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Patient defined dichotomous end points for remission and clinical improvement in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

THE COURSE AND PROGNOSIS OF ULCERATIVE COLITIS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Ulcerative colitis and colorectal cancer. A population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Dysplasia and Cancer in Inflammatory Bowel Disease 10 Years after Diagnosis: Results of a Population-Based European Collaborative Follow-Up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Correlation of C-reactive protein with clinical, endoscopic, histologic, and radiographic activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Development, validation, and evaluation of a pediatric ulcerative colitis activity index: a prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Serum procalcitonin differentiates inflammatory bowel disease and self-limited colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

The role of C-reactive protein as an inflammatory marker in gastrointestinal diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Role of faecal calprotectin as non-invasive marker of intestinal inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Enzymes in feces: useful markers of chronic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Faecal elastase reflects disease activity in active ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Faecal S100A12 as a non-invasive marker distinguishing inflammatory bowel disease from irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and ulcerative colitis: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

The value of serologic markers in indeterminate colitis: a prospective follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Anti-flagellin (CBir1) phenotypic and genetic Crohn's disease associations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

A genome-wide association study identifies IL23R as an inflammatory bowel disease gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Genetic variation in DLG5 is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

MDR1 Ala893 polymorphism is associated with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Lack of association between the C3435T MDR1 gene polymorphism and inflammatory bowel disease in two independent Northern European populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Deficient host-bacteria interactions in inflammatory bowel disease? The toll-like receptor (TLR)-4 Asp299gly polymorphism is associated with Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Genetic markers may predict disease behavior in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

IBD5 is a general risk factor for inflammatory bowel disease: replication of association with Crohn disease and identification of a novel association with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Clinical epidemiology of inflammatory bowel disease: Incidence, prevalence, and environmental influences

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Endoscopy in inflammatory bowel disease: indications, surveillance, and use in clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Clinical appearance at diagnosis of ulcerative colitis and Crohn's disease in a regional patient group

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Symptoms and stool patterns in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

From symptom to diagnosis: clinical distinctions among various forms of intestinal inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Ulcerative colitis: diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

AGA technical review on the evaluation and management of chronic diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Inflammatory bowel disease: clinical aspects and established and evolving therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Extraintestinal manifestations in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Inflammation and coagulation in inflammatory bowel disease: The clot thickens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Smoking and inflammatory bowel disease: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Impact of cessation of smoking on the course of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Inflammatory bowel disease and smoking: a review of epidemiology, pathophysiology, and therapeutic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Primary sclerosing cholangitis is associated with nonsmoking: a case-control study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Appendectomy and subsequent risk of inflammatory bowel diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Role of appendicitis and appendectomy in the pathogenesis of ulcerative colitis: a critical review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Effects of appendicectomy on the course of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Epidemiology of appendicectomy in primary sclerosing cholangitis and ulcerative colitis: its influence on the clinical behaviour of these diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Systematic review: is ingestion of paracetamol or non-steroidal anti-inflammatory drugs associated with exacerbations of inflammatory bowel disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Selective use of selective nonsteroidal anti-inflammatory drugs in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Safety of celecoxib in patients with ulcerative colitis in remission: a randomized, placebo-controlled, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

An open-label trial of the selective cyclo-oxygenase-2 inhibitor, rofecoxib, in inflammatory bowel disease-associated peripheral arthritis and arthralgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Review article: genetic susceptibility and application of genetic testing in clinical management of inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Familial occurrence of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Familial Crohn??s Disease in Belgium

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Update on the etiology, pathogenesis and diagnosis of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Unravelling the pathogenesis of inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

A population-based case control study of potential risk factors for IBD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Risk factors for inflammatory bowel disease in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Are there any differences in phenotype or disease course between familial and sporadic cases of inflammatory bowel disease? Results of a population-based follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Change of diagnosis during the first five years after onset of inflammatory bowel disease: results of a prospective follow-up study (the IBSEN Study).

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

CRP correlates with clinical score in ulcerative colitis but not in Crohn's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

C-reactive protein as a marker for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Predicting outcome in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Search for enteric microbial pathogens in patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Incidence of Clostridium difficile infection in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Clostridium difficile associated diarrhoea in hospitalised patients: onset in the community and hospital and role of flexible sigmoidoscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Cytomegalovirus infection in severe ulcerative colitis patients undergoing continuous intravenous cyclosporine treatment in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Cytomegalovirus is frequently reactivated and disappears without antiviral agents in ulcerative colitis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Frequent detection of cytomegalovirus in the intestine of patients with inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

The prevalence of genetic and serologic markers in an unselected European population-based cohort of IBD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Interassay and interobserver variability in the detection of anti-neutrophil cytoplasmic antibodies in patients with ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Do serological markers and cytokines determine the indeterminate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Laboratory markers in IBD: useful, magic, or unnecessary toys?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Review article: faecal markers in the assessment of activity in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Patterns of colonic involvement at initial presentation in ulcerative colitis: a retrospective study of 46 newly diagnosed cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Assessment of severity in colitis: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Small bowel gas in severe ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Methylene blue-aided chromoendoscopy for the detection of intraepithelial neoplasia and colon cancer in ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Treatment of ulcerative colitis with a humanized antibody to the alpha4beta7 integrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Ultrasonography in the evaluation of extension, activity, and follow-up of ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Mesenteric blood flow is related to disease activity and risk of relapse in ulcerative colitis: a prospective follow up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Mesenteric pulsatility index analysis predicts response to azathioprine in patients with Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Active inflammatory bowel disease: evaluation with 99mTc (V) DMSA scintigraphy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Magnetic resonance colonography for the detection of inflammatory diseases of the large bowel: quantifying the inflammatory activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

MR colonography in inflammatory bowel disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

A Meta-Analysis of the Yield of Capsule Endoscopy Compared to Other Diagnostic Modalities in Patients with Non-Stricturing Small Bowel Crohn's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Multi-detector CT-colonography in inflammatory bowel disease: prospective analysis of CT-findings to high-resolution video colonoscopy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Does quantitative histology of rectal biopsy improve the differential diagnosis of Crohn's disease and ulcerative colitis in adults?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Observer variability in the histopathological reporting of abnormal rectal biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Reliability of rectal biopsy in distinguishing between chronic inflammatory bowel disease and acute self-limiting colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Observer variation and discriminatory value of biopsy features in inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Simple mucosal biopsy criteria differentiating among Crohn disease, ulcerative colitis, and other forms of colitis: measurement of validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Histopathology of ulcerative colitis in initial rectal biopsy in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

How could pathologists improve the initial diagnosis of colitis? Evidence from an international workshop

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Diagnosing colitis: a prospective study on essential parameters for reaching a diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Guidelines for the initial biopsy diagnosis of suspected chronic idiopathic inflammatory bowel disease. The British Society of Gastroenterology Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Gastrin increases murine intestinal crypt regeneration following injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Pathologic features and clinical significance of "backwash" ileitis in ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

An analysis of the reliability of detection and diagnostic value of various pathological features in Crohn's disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Pediatric patients with untreated ulcerative colitis may present initially with unusual morphologic findings.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Microscopic activity in ulcerative colitis: what does it mean?

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Pit patterns in rectal mucosa assessed by magnifying colonoscope are predictive of relapse in patients with quiescent ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Histologic predictors of pouchitis in patients with chronic ulcerative colitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Role of early ultrasound in detecting inflammatory intestinal disorders and identifying their anatomical location within the bowel

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

Polymorphisms in multidrug resistance 1 (MDR1) gene are associated with refractory Crohn disease and ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.CROHNS.2007.11.001

10.1016/J.CROHNS.2007.11.001

21 January 2018

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21172194%20AND%20SRC:MED&resulttype=core&format=json

18 January 2020

1 reference